← Back to catalogue

Port Access Infusion Set

FDA UDI

Class II (US FDA UDI)

by Sb-Kawasumi Laboratories, Inc.

Identity

Trade Name
PORT ACCESS INFUSION SET FDA UDI
Generic Name
Vascular port administration set FDA UDI
Device Name
Access needle with Infusion Set used for the delivery of medications to indwelling medication ports. Fluid administered through the Port Access Infusion Set are those generally used in hospitals, and for chemotherapy. FDA UDI
Model / Reference
PI03091 FDA UDI
Description
Access needle with Infusion Set used for the delivery of medications to indwelling medication ports. Fluid administered through the Port Access Infusion Set are those generally used in hospitals, and for chemotherapy. FDA UDI

Identifiers

Catalog Number
PI03091 FDA UDI
Primary DI / UDI-DI
04987488102272 FDA UDI
FDA Product Code
FRN FDA UDI
GMDN Term
Vascular port administration set FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
880.5725 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

Yes

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

Yes

FDA UDI

Dimensions & Sizes

Size
Needle Gauge — 19 Gauge FDA UDI

Category: Vascular port administration set

Port Access Infusion Set by Sb-Kawasumi Laboratories, Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Vascular port administration set.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 0d41aec3-80dc-47de-931d-efa4aeb6bf0b 36 fields · synced Jun 7, 2026